Compounds of the formula
##STR1##
and their pharmaceutically acceptable salts, wherein R1, R2,
and R3 are defined as in the specification, intermediates in the synthesis
of such compounds, pharmaceutical compositions containing such compounds and methods
of using such compounds in the treatment of neurological and psychological disorders.
